Corcept Therapeutics
CORT
#2582
Rank
โ‚น449.93 B
Marketcap
โ‚น4,294
Share price
-3.56%
Change (1 day)
110.77%
Change (1 year)

P/S ratio for Corcept Therapeutics (CORT)

P/S ratio as of January 2025 (TTM): 8.24

According to Corcept Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.11. At the end of 2024 the company had a P/S ratio of 7.30.

P/S ratio history for Corcept Therapeutics from 2007 to 2024

20082012201620202024500010000150002000025000300000companiesmarketcap.com

PS ratio at the end of each year

Year P/S ratio Change
20247.305.22%
20236.9427.57%
20225.44-12.9%
20216.25-27.27%
20208.5989.9%
20194.52-26.07%
20186.12-52.75%
201712.930.61%
20169.91-8.71%
201510.9-5.22%
201411.5-62.98%
201330.9-28.3%
201243.2
2011N/A
2010N/A-100%
2009> 10006549.54%
200887.1-60.46%
2007220

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
3.92-52.42%๐Ÿ‡บ๐Ÿ‡ธ USA
2.42-70.70%๐Ÿ‡บ๐Ÿ‡ธ USA
4.00-51.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
17.5 112.66%๐Ÿ‡บ๐Ÿ‡ธ USA
2.54-69.16%๐Ÿ‡บ๐Ÿ‡ธ USA
4.00-51.51%๐Ÿ‡บ๐Ÿ‡ธ USA
1.50-81.83%๐Ÿ‡บ๐Ÿ‡ธ USA
6.24-24.30%๐Ÿ‡บ๐Ÿ‡ธ USA
4.60-44.14%๐Ÿ‡บ๐Ÿ‡ธ USA